Clinical Trials in Philadelphia

Showing 6321-6340 of 20,904 trials

Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck

NCT02289209

Eligible participants with locoregional inoperable recurrence or second primary squamous cell carcinoma of the head and neck will be treated with reirradiation combined with anti-PD-1 mAb MK-3475 (generic name: pembrolizumab, trade name Keytruda®).

Recurrent Head and Neck CancerCarcinoma, Squamous Cell of Head and Neck

Dan Zandberg48 participantsStarted Mar 2016

Baltimore, Maryland, United States • Baltimore, Maryland, United States • Philadelphia, Pennsylvania, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

NCT03988634

The effect of sacubitril/valsartan vs. valsartan on changes in NT-proBNP, safety, and tolerability in HFpEF patients with a WHF event (HFpEF decompensation) who had been stabilized and initiated at the time of or within 30 days post-decompensation.

Heart Failure With Preserved Ejection Fraction (HFpEF)

Novartis Pharmaceuticals467 participantsStarted Jun 2019

Irvine, California, United States • Long Beach, California, United States • Los Angeles, California, United States +94 more locations

Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

Find Trials by Condition in Philadelphia

Neural Mechanisms Associated With Risk of Smoking Relapse

ASSIST: Treatment for Childhood Apraxia of Speech

A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)

Exercise and Motor Learning After Stroke (Study #3)

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

MGD019 DART® Protein in Unresectable/Metastatic Cancer

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

ViBone in Cervical and Lumbar Spine Fusion

Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing Pleuroscopy